BRPI0905078A2 - Methods for treating intervertebral disc herniation and reducing the size of an intervertebral disc hernia and implantable drug deposition - Google Patents

Methods for treating intervertebral disc herniation and reducing the size of an intervertebral disc hernia and implantable drug deposition

Info

Publication number
BRPI0905078A2
BRPI0905078A2 BRPI0905078-7A BRPI0905078A BRPI0905078A2 BR PI0905078 A2 BRPI0905078 A2 BR PI0905078A2 BR PI0905078 A BRPI0905078 A BR PI0905078A BR PI0905078 A2 BRPI0905078 A2 BR PI0905078A2
Authority
BR
Brazil
Prior art keywords
intervertebral disc
reducing
methods
size
implantable drug
Prior art date
Application number
BRPI0905078-7A
Other languages
Portuguese (pt)
Inventor
Vanja Margaretta King
John Myers Zanella
Jared T Wilsey
Original Assignee
Medtronic Inc
Warsaw Orthopedic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/105,864 external-priority patent/US8524267B2/en
Priority claimed from US12/396,122 external-priority patent/US9492461B2/en
Application filed by Medtronic Inc, Warsaw Orthopedic Inc filed Critical Medtronic Inc
Publication of BRPI0905078A2 publication Critical patent/BRPI0905078A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0905078-7A 2008-04-18 2009-04-10 Methods for treating intervertebral disc herniation and reducing the size of an intervertebral disc hernia and implantable drug deposition BRPI0905078A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4621808P 2008-04-18 2008-04-18
US12/105,864 US8524267B2 (en) 2008-04-18 2008-04-18 Dexamethasone formulations in a biodegradable material
US12/396,122 US9492461B2 (en) 2008-04-18 2009-03-02 Methods and compositions for treating intervertebral disc herniations
PCT/US2009/040234 WO2009129148A2 (en) 2008-04-18 2009-04-10 Methods and compositions for treating intervertebral disc herniations

Publications (1)

Publication Number Publication Date
BRPI0905078A2 true BRPI0905078A2 (en) 2015-06-30

Family

ID=42670674

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0905078-7A BRPI0905078A2 (en) 2008-04-18 2009-04-10 Methods for treating intervertebral disc herniation and reducing the size of an intervertebral disc hernia and implantable drug deposition

Country Status (5)

Country Link
EP (1) EP2234619A4 (en)
JP (1) JP2011513337A (en)
CN (1) CN101918002B (en)
BR (1) BRPI0905078A2 (en)
WO (1) WO2009129148A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125902B2 (en) * 2010-01-28 2015-09-08 Warsaw Orthopedic, Inc. Methods for treating an intervertebral disc using local analgesics
US9050274B2 (en) * 2010-01-28 2015-06-09 Warsaw Orthopedic, Inc. Compositions and methods for treating an intervertebral disc using bulking agents or sealing agents
TWI624262B (en) * 2013-01-23 2018-05-21 桑紐爾製藥公司 Pharmaceutical formulation
TWI772659B (en) 2015-01-21 2022-08-01 美商桑紐爾製藥公司 Pharmaceutical formulation
CN110585423A (en) * 2019-10-24 2019-12-20 内蒙古医科大学第二附属医院 Application of IL-6 in preparation of medicine for treating lumbar disc herniation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920702383A (en) * 1989-08-28 1992-09-03 원본미기재 Biocorrosive polymers useful for controlling the release of therapeutic agents
US20050048099A1 (en) * 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
CN1863557B (en) * 2003-06-26 2010-06-16 普西维达公司 In-situ gelling drug delivery system
US8642060B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for osteal growth
US8802128B2 (en) * 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20080317805A1 (en) * 2007-06-19 2008-12-25 Mckay William F Locally administrated low doses of corticosteroids

Also Published As

Publication number Publication date
EP2234619A4 (en) 2010-10-27
EP2234619A2 (en) 2010-10-06
WO2009129148A2 (en) 2009-10-22
CN101918002B (en) 2013-06-26
JP2011513337A (en) 2011-04-28
CN101918002A (en) 2010-12-15
WO2009129148A3 (en) 2010-01-28

Similar Documents

Publication Publication Date Title
BRPI0810946A2 (en) METHOD FOR DISK HERNIA TREATMENT
BRPI0814523A2 (en) BIOCOMPATIBLE IMPLANT, METHOD FOR FORMATION OF BIOCOMPATIBLE IMPLANT AND METHOD OF APPLICATION
BRPI0923624A2 (en) insole, and methods for mounting an insole, and for relieving arthritis pain
BR112012022211A2 (en) compound. pharmaceutical composition, method of treating a disease mediated by h4r, method of inhibiting h4h, method of treating pain or inflammation resulting from cataract surgery, method of achieving an effect on a patient and use of a compound
BRPI0807717A2 (en) KINASE INHIBITORS USEFUL FOR TREATMENT OF MYELOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES.
IL219605A0 (en) Systems, apparatuses and methods for treating tissue and controlling stenosis
BRPI0813311A2 (en) COMPOUND, METHODS FOR MODULATING THE ACTIVITY OF A PROTEIN KINASE AND FOR TREATING CANCER IN AN INDIVIDUAL AND PHARMACEUTICAL COMPOSITION.
WO2008036502A3 (en) Artificial spinal disc
BRPI0921321A2 (en) methods for the treatment of tumors and tumors
BRPI0914950A2 (en) implants, systems and techniques for increasing the mechanical advantage of bone screws
BRPI0815387A2 (en) pharmaceutical composition, method of making a pharmaceutical composition and method of treating a condition
EP2337535A4 (en) Systems, devices and methods for the treatment of tinnitus
GB201011313D0 (en) Implantation devices, methods and implants
BRPI0922191A2 (en) artificial intervertebral disc
ZA201000279B (en) Tissue fragment composition for the treatment of incontinence
EP2079389A4 (en) Resorbable pouches for implantable medical devices
BRPI0811581A2 (en) GSC STIMULATORS, GSC ACTIVITIES AND COMBINATIONS FOR THE TREATMENT OF UROLOGICAL DISORDERS
BRPI0911612A2 (en) compositions and methods for the treatment of multiple sclerosis.
BRPI0912539A2 (en) compound, pharmaceutical composition, method for treating a disease, and use of the compound.
BRPI0816712A2 (en) interval therapy for the treatment of tinnitus
BRPI0820802A2 (en) Materials and methods for treating pathological ocular vascular proliferation
BRPI0818323A2 (en) pharmaceutical composition, use of a pharmaceutical composition, and method for treating cancer.
BRPI0905078A2 (en) Methods for treating intervertebral disc herniation and reducing the size of an intervertebral disc hernia and implantable drug deposition
AU2009231892A8 (en) Methods of diagnosing, preventing and treating bone mass diseases
EP2268312A4 (en) Treatment of intervertebral disc degeneration

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.